Dr Julie Suman
Vice-President, Scientific Affairs

Is this your profile?

About

Julie Suman, PhD, is the Vice-President of Scientific Affairs for Aptar Pharma. She holds a BSc in Pharmacy and a PhD in Pharmaceutical Sciences. Dr Suman is co-editor for Respiratory Drug Delivery Proceedings and an Affiliate Assistant Professor in the Department of Pharmaceutics at Virginia Commonwealth University (VA, US). A past Chair of the AAPS Inhalation Technology Focus Group, Dr Suman has published in several peer-reviewed journals and presented at numerous international meetings.

Contributions

Interview: EXPLORING NASAL CASTS IN NASAL DRUG DEVELOPMENT

Julie Suman discusses nasal casts, their development, applications and significance for nasal drug product development.

More contributions

ADVANCING OINDP CLINICAL TRIALS WITH SPEED AND EFFICIENCY: STRATEGIES FOR SUCCESS

Gemma Budd and Julie Suman, consider the key issues that preclinical and clinical trials for orally inhaled and nasal drug products must address within the context of the information that regulators are looking for, providing insight, strategies and advice for both novel and generic products in this sector.

THE POTENTIAL AND THE CHALLENGES OF NASAL VACCINATION

Julie Suman and Nektaria Karavas discuss the challenges and opportunities of intranasal vaccination – showcasing current understanding for both liquid and powder products. Experimental studies highlight critical issues, the performance of commercially available devices and developments in formulation practice.

USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY

Justin Lacombe and Julie D Suman explain how applying quality by design principles to combination products improves development efficiency, aligns with design controls, and maximises product safety and efficacy.

DELIVERING ON THE PROMISES OF INTRANASAL VACCINATION

Julie Suman and Nektaria Karavas review intranasal delivery as a method of vaccine administration and consider the challenges and benefits of intranasal delivery.

HOW EVOLVING PATIENT NEEDS HAVE FUELLED THE DEVELOPMENT OF NASAL DRUG DELIVERY

Julie Suman considers how the needs of the patient have driven advances in nasal drug delivery and looks at the latest developments and benefits of this method of drug delivery.

REDUCE RISKS, MITIGATE FAILURE & DRIVE TIMELINES IN A COMPETITIVE MARKET

Badre Hammond, Shailuja Somaraju and Julie Suman highlight key considerations and present strategies to reduce risk and ultimately accelerate the process for gaining approval of an ophthalmic product, with a focus on the US.

Top